Home/Filings/4/0001093557-23-000059
4//SEC Filing

Regan Barry J. 4

Accession 0001093557-23-000059

CIK 0001093557other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 4:01 PM ET

Size

5.2 KB

Accession

0001093557-23-000059

Insider Transaction Report

Form 4
Period: 2023-03-08
Regan Barry J.
EVP Operations
Transactions
  • Award

    Common Stock

    2023-03-08$0.00/sh+18,776$1978,162 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 62,632 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001746313

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:01 PM ET
Size
5.2 KB